The mitochondrial thioredoxin system regulates nitric oxide-induced HIF-1α protein

Free Radical Biology and Medicine

Volumn 44, Issue 1, 2008, Pages 91-98

  Zhou, Jie ^a   Eleni, Chantzoura ^b   Spyrou, Giannis ^b   Brüne, Bernhard ^a  

^a GOETHE UNIVERSITY   (Germany)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

ATP; Free radicals; MAPK; Mitochondria; Protein translation

Indexed keywords

ADENOSINE TRIPHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; PROTEIN KINASE B; THIOREDOXIN; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 2; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEOMICS;

ANIMALS; CELL COMMUNICATION; CELL HYPOXIA; CELL LINE; COCULTURE TECHNIQUES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MACROPHAGE ACTIVATION; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MITOCHONDRIAL PROTEINS; NITRIC OXIDE; THIOREDOXIN REDUCTASE 2; THIOREDOXINS; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 36249026245     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.09.012     Document Type: Article

References (29)

1. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev., Cancer 3 (2003) 721-732
2. Pugh C.W., and Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9 (2003) 677-684
3. Zhou J., and Brune B. Cytokines and hormones in the regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Cardiovasc. Hematol. Agents Med. Chem. 4 (2006) 189-197
4. Metzen E., Zhou J., Jelkmann W., Fandrey J., and Brüne B. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol. Biol. Cell 14 (2003) 3470-3481
5. Kasuno K., Takabuchi S., Fukuda K., Kizaka-Kondoh S., Yodoi J., Adachi T., Semenza G.L., and Hirota K. Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling. J. Biol. Chem. 279 (2004) 2550-2558
6. Arner E.S., and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267 (2000) 6102-6109
7. Vlamis-Gardikas A., and Holmgren A. Thioredoxin and glutaredoxin isoforms. Methods Enzymol. 347 (2002) 286-296
8. Huang L.E., Arany Z., Livingston D.M., and Bunn H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 271 (1996) 32253-32259
9. Ema M., Hirota K., Mimura J., Abe H., Yodoi J., Sogawa K., Poellinger L., and Fujii-Kuriyama Y. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18 (1999) 1905-1914
10. Zhou J., Damdimopoulos A.E., Spyrou G., and Brune B. Thioredoxin 1 and thioredoxin 2 have opposed regulatory functions on hypoxia inducible factor-1alpha. J. Biol. Chem. 280 (2007) 7482-7490
11. Welsh S.J., Bellamy W.T., Briehl M.M., and Powis G. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 62 (2002) 5089-5095
12. Moos P.J., Edes K., Cassidy P., Massuda E., and Fitzpatrick F.A. Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J. Biol. Chem. 278 (2003) 745-750
13. Jewell U.R., Kvietikova I., Scheid A., Bauer C., Wenger R.H., and Gassmann M. Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J. 15 (2001) 1312-1314
14. Kim W.J., Cho H., Lee S.W., Kim Y.J., and Kim K.W. Antisense-thioredoxin inhibits angiogenesis via pVHL-mediated hypoxia-inducible factor-1alpha degradation. Int. J. Oncol. 26 (2005) 1049-1052
15. Kohl R., Zhou J., and Brune B. Reactive oxygen species attenuate nitric-oxide-mediated hypoxia-inducible factor-1alpha stabilization. Free Radic. Biol. Med. 40 (2006) 1430-1442
16. Thomas D.D., Ridnour L.A., Espey M.G., Donzelli S., Ambs S., Hussain S.P., Harris C.C., Degraff W., Roberts D.D., Mitchell J.B., and Wink D.A. Superoxide fluxes limit nitric oxide-induced signaling. J. Biol. Chem. 281 (2006) 25984-25993
17. Robinson M.J., Stippec S.A., Goldsmith E., White M.A., and Cobb M.H. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8 (1998) 1141-1150
18. Weg-Remers S., Ponta H., Herrlich P., and Konig H. Antagonistic signaling pathways regulate alternative splicing of CD44 in T cells. Ann. N. Y. Acad. Sci. 973 (2002) 112-115
19. Damdimopoulos A.E., Miranda-Vizuete A., Pelto-Huikko M., Gustafsson J.A., and Spyrou G. Human mitochondrial thioredoxin: involvement in mitochondrial membrane potential and cell death. J. Biol. Chem. 277 (2002) 33249-33257
20. Nalvarte I., Damdimopoulos A.E., Nystom C., Nordman T., Miranda-Vizuete A., Olsson J.M., Eriksson L., Bjornstedt M., Arner E.S., and Spyrou G. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells: effect on cell growth and differentiation. J. Biol. Chem. 279 (2004) 54510-54517
21. Fukuda R., Hirota K., Fan F., Jung Y.D., Ellis L.M., and Semenza G.L. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277 (2002) 38205-38211
22. Laughner E., Taghavi P., Chiles K., Mahon P.C., and Semenza G.L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21 (2001) 3995-4004
23. Brugarolas J., and Kaelin Jr. W.G. Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes. Cancer Cell 6 (2004) 7-10
24. Brugarolas J., Lei K., Hurley R.L., Manning B.D., Reiling J.H., Hafen E., Witters L.A., Ellisen L.W., and Kaelin Jr. W.G. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18 (2004) 2893-2904
25. Buckman J.F., and Reynolds I.J. Spontaneous changes in mitochondrial membrane potential in cultured neurons. J. Neurosci. 21 (2001) 5054-5065
26. Miki J., Maeda M., Mukohata Y., and Futai M. The γ-subunit of ATP synthase from spinach chloroplasts Primary structure deduced from the cloned cDNA sequence. FEBS Lett. 232 (1998) 221-226
27. Belogrudov G.I., and Hatefi Y. Factor B and the mitochondrial ATP synthase complex. J. Biol. Chem. 277 (2002) 6097-6103
28. Brüne B., and Zhou J. The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Curr. Med. Chem. 10 (2003) 845-855
29. Wellman T.L., Jenkins J., Penar P.L., Tranmer B., Zahr R., and Lounsbury K.M. Nitric oxide and reactive oxygen species exert opposing effects on the stability of hypoxia inducible factor-1alpha (HIF-1alpha) in explants of human pial arteries. FASEB J. 18 (2004) 379-381